{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:02:50Z","timestamp":1781215370895,"version":"3.54.1"},"reference-count":218,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Stroke is the leading cause of morbidity and mortality in diabetic patients. Diabetes alters\nthe endothelial function and disrupts brain pathways, resulting in a variety of systemic metabolic complications.\nDiabetics not only have impaired neurotransmission, but also have progressive neurodegeneration,\nwhich leads to long-term neurological complications. Diabetes risk factors and physiology\nalter the frequency and severity of cardiovascular and cerebrovascular events, necessitating more\nhospitalizations. Stroke and diabetes have a mutually reinforcing relationship that worsens their outcomes.\nDiabetes has far-reaching systemic consequences for human physiology as a metabolic syndrome.\nAs a result, diabetic stroke patients require dual-therapeutics with dual protection. Scientific\nresearchers have made tremendous progress in diabetes-related stroke and its therapeutics over the last\nfew decades. We have summarised diabetic brain and associated risk factors, co-morbidities, biomarkers,\nand hyperglycemia-associated neurovascular insult and cognitive demur. In addition to\nproviding an overview of the effects of hyperglycaemia on brain physiology, this article aims to summarise\nthe evidence from current glucose-lowering treatment, recent advances in stroke therapeutics as\nwell as exploring stem cell therapy in the management of diabetes-associated stroke.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527321666220609200852","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T06:13:39Z","timestamp":1655100819000},"page":"832-856","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hyperglycaemic Metabolic Complications of Ischemic Brain: Current\nTherapeutics, Anti-Diabetics and Stem Cell Therapy"],"prefix":"10.2174","volume":"22","author":[{"given":"Vishal","family":"Chavda","sequence":"first","affiliation":[{"name":"Pharmacology Research Lab, Department of Pharmacology, Nirma University, Ahmedabad, Gujarat 382481, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Patel","sequence":"additional","affiliation":[{"name":"Pharmacology Research Lab, Department of Pharmacology, Nirma University, Ahmedabad, Gujarat 382481, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2012","unstructured":"Intercollegiate Stroke Working Party. National clinical guideline for stroke, 4th edition. London: Royal College of Physicians 2012"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/187153012800493477","volume":"12","author":"Ergul A.","year":"2012","unstructured":"Ergul A.; Kelly-Cobbs A.; Abdalla M.; Fagan S.C.; Cerebrovascular complications of diabetes: Focus on stroke. Endocr. Metab. Immune Disord. Drug Targets 2012,12(2),148-158"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.4172\/2155-6156.1000544","volume":"6","author":"Tuttolomondo A.","year":"2015","unstructured":"Tuttolomondo A.; Maida C.; Maugeri R.; Iacopino G.; Pinto A.; Relationship between diabetes and ischemic stroke: Analysis of diabetes-related risk factors for stroke and of specific patterns of stroke associated with diabetes mellitus. J. Diabetes Metab. 2015,6(5),544"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1212\/01.WNL.0000123252.55688.05","volume":"62","author":"Karapanayiotides T.","year":"2004","unstructured":"Karapanayiotides T.; Piechowski-Jozwiak B.; van Melle G.; Bogousslavsky J.; Devuyst G.; Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology 2004,62(9),1558-1562"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.amjms.2016.01.011","volume":"351","author":"Chen R.","year":"2016","unstructured":"Chen R.; Ovbiagele B.; Feng W.; Diabetes and stroke: Epidemiology, pathophysiology, pharmaceuticals and outcomes. Am. J. Med. Sci. 2016,351(4),380-386"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"Saeedi P.","year":"2019","unstructured":"Saeedi P.; Inga P.; Paraskevi S.; Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas. Diabetes Res. Clin. Pract. 2019,157(107843)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e0167327","DOI":"10.1371\/journal.pone.0167327","volume":"11","author":"Li P.","year":"2016","unstructured":"Li P.; Quan W.; Lu D.; Association between metabolic syndrome and cognitive impairment after acute ischemic stroke: A cross-sectional study in a Chinese population. PLoS One 2016,11(12),e0167327"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1159\/000360810","volume":"37","author":"Fonville S.","year":"2014","unstructured":"Fonville S.; Zandbergen A.A.M.; Koudstaal P.J.; den Hertog H.M.; Prediabetes in patients with stroke or transient ischemic attack: Prevalence, risk and clinical management. Cerebrovasc. Dis. 2014,37(6),393-400"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2337\/dc06-1537","volume":"30","author":"Air E.L.","year":"2007","unstructured":"Air E.L.; Kissela B.M.; Diabetes, the metabolic syndrome, and ischemic stroke: Epidemiology and possible mechanisms. Diabetes Care 2007,30(12),3131-3140"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1161\/STROKEAHA.111.641381","volume":"43","author":"Banerjee C.","year":"2012","unstructured":"Banerjee C.; Moon Y.P.; Paik M.C.; Duration of diabetes and risk of ischemic stroke: The northern manhattan study. Stroke 2012,43(5),1212-1217"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","volume":"36","author":"Mergenthaler P.","year":"2013","unstructured":"Mergenthaler P.; Lindauer U.; Dienel G.A.; Meisel A.; Sugar for the brain: The role of glucose in physiological and pathological brain function. Trends Neurosci. 2013,36(10),587-597"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/B978-0-12-027310-2.50016-5","volume":"10","author":"Frank H.J.","year":"1983","unstructured":"Frank H.J.; Pardridge W.M.; Insulin binding to brain microvessels. Adv. Metab. Disord. 1983,10,291-302"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"E462","DOI":"10.1152\/ajpendo.1984.247.4.E462","volume":"247","author":"McCall A.L.","year":"1984","unstructured":"McCall A.L.; Gould J.B.; Ruderman N.B.; Diabetes-induced alterations of glucose metabolism in rat cerebral microvessels. Am. J. Physiol. 1984,247(4 Pt 1),E462-E467"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1471-4159.2006.04115.x","volume":"99","author":"Lei H.","year":"2006","unstructured":"Lei H.; Gruetter R.; Effect of chronic hypoglycaemia on glucose concentration and glycogen content in rat brain: A localized 13C NMR study. J. Neurochem. 2006,99(1),260-268"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/BF00417687","volume":"37","author":"Biessels G.J.","year":"1994","unstructured":"Biessels G.J.; Kappelle A.C.; Bravenboer B.; Erkelens D.W.; Gispen W.H.; Cerebral function in diabetes mellitus. Diabetologia 1994,37(7),643-650"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13340-013-0132-0","volume":"5","author":"Go Y.","year":"2014","unstructured":"Go Y.; Kitaoka H.; Hanafusa T.; Effects of diabetes and diabetes control on susceptibility to learned helplessness in streptozotocin-induced diabetic rats. Diabetol. Int. 2014,5(1),53-61"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1177\/0193945914524491","volume":"36","author":"Penckofer S.","year":"2014","unstructured":"Penckofer S.; Doyle T.; Byrn M.; Lustman P.J.; State of the science: Depression and type 2 diabetes. West. J. Nurs. Res. 2014,36(9),1158-1182"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2337\/diaspect.21.3.160","volume":"21","author":"Dokken B.B.","year":"2008","unstructured":"Dokken B.B.; The pathophysiology of cardiovascular disease and diabetes: Beyond blood pressure and lipids. Diabetes Spectr. 2008,21(3),160-165"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","volume":"32","author":"Sandoval K.E.","year":"2008","unstructured":"Sandoval K.E.; Witt K.A.; Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol. Dis. 2008,32(2),200-219"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/25785826.2018.1531190","volume":"41","author":"Shimizu F.","year":"2018","unstructured":"Shimizu F.; Nishihara H.; Kanda T.; Blood-brain barrier dysfunction in immuno-mediated neurological diseases. Immunol. Med. 2018,41(3),120-128"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1523\/JNEUROSCI.2810-14.2015","volume":"35","author":"Reeson P.","year":"2015","unstructured":"Reeson P.; Tennant K.A.; Gerrow K.; Delayed inhibition of VEGF signaling after stroke attenuates blood-brain barrier breakdown and improves functional recovery in a comorbidity-dependent manner. J. Neurosci. 2015,35(13),5128-5143"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.2174\/138161212802002841","volume":"18","author":"Borlongan C.V.","year":"2012","unstructured":"Borlongan C.V.; Glover L.E.; Sanberg P.R.; Hess D.C.; Permeating the blood brain barrier and abrogating the inflammation in stroke: Implications for stroke therapy. Curr. Pharm. Des. 2012,18(25),3670-3676"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.3892\/mmr.2017.7027","volume":"16","author":"Wang S.","year":"2017","unstructured":"Wang S.; Wang J.; Zhao A.; Li J.; SIRT1 activation inhibits hyperglycemia-induced apoptosis by reducing oxidative stress and mitochondrial dysfunction in human endothelial cells. Mol. Med. Rep. 2017,16(3),3331-3338"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.redox.2018.09.025","volume":"20","author":"Yuan T.","year":"2019","unstructured":"Yuan T.; Yang T.; Chen H.; New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 2019,20,247-260"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","volume":"100","author":"Incalza M.A.","year":"2018","unstructured":"Incalza M.A.; D\u2019Oria R.; Natalicchio A.; Perrini S.; Laviola L.; Giorgino F.; Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul. Pharmacol. 2018,100,1-19"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1253\/circj.CJ-11-0121","volume":"75","author":"Mogi M.","year":"2011","unstructured":"Mogi M.; Horiuchi M.; Neurovascular coupling in cognitive impairment associated with diabetes mellitus. Circ. J. 2011,75(5),1042-1048"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.bbrc.2013.09.086","volume":"440","author":"Shah G.N.","year":"2013","unstructured":"Shah G.N.; Morofuji Y.; Banks W.A.; Price T.O.; High glucose-induced mitochondrial respiration and reactive oxygen species in mouse cerebral pericytes is reversed by pharmacological inhibition of mitochondrial carbonic anhydrases: Implications for cerebral microvascular disease in diabetes. Biochem. Biophys. Res. Commun. 2013,440(2),354-358"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/0004563213508747","volume":"51","author":"Dias I.H.","year":"2014","unstructured":"Dias I.H.; Griffiths H.R.; Oxidative stress in diabetes - circulating advanced glycation end products, lipid oxidation and vascular disease. Ann. Clin. Biochem. 2014,51(Pt 2),125-127"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/dom.12120","volume":"15","author":"Shao B.","year":"2013","unstructured":"Shao B.; Bayraktutan U.; Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-\u03b2. Diabetes Obes. Metab. 2013,15(11),993-999"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.vph.2012.05.005","volume":"57","author":"Ceriello A.","year":"2012","unstructured":"Ceriello A.; The emerging challenge in diabetes: the \u201cmetabolic memory\u201d. Vascul. Pharmacol. 2012,57(5-6),133-138"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e0152376","DOI":"10.1371\/journal.pone.0152376","volume":"11","author":"Serban A.I.","year":"2016","unstructured":"Serban A.I.; Stanca L.; Geicu O.I.; Munteanu M.C.; Dinischiotu A.; RAGE and TGF-\u03b21 cross-talk regulate extracellular matrix turnover and cytokine synthesis in AGes exposed fibroblast cells. PLoS One 2016,11(3),e0152376"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9780470015902.a0027298","author":"Rojas A","year":"2017","unstructured":"Rojas A; Morales MA; Araya P; Gonz\u00e1lez I; RAGE - The receptor of advanced glycation end products. eLS 2017,1-7"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e45499","DOI":"10.1371\/journal.pone.0045499","volume":"7","author":"Wang S.","year":"2012","unstructured":"Wang S.; Cao C.; Chen Z.; Pericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammation. PLoS One 2012,7(9),e45499"},{"key":"ref=34","first-page":"673","volume":"21","author":"Kim L.A.","year":"2015","unstructured":"Kim L.A.; Wong L.L.; Amarnani D.S.; Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy. Mol. Vis. 2015,21,673-687"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1620\/tjem.231.217","volume":"231","author":"Safiah Mokhtar S","year":"2013","unstructured":"Safiah Mokhtar S; M Vanhoutte P, W S Leung S, et al. Reduced expression of prostacyclin synthase and nitric oxide synthase in subcutaneous arteries of type 2 diabetic patients. Tohoku J. Exp. Med. 2013,231(3),217-222"},{"key":"ref=36","author":"De Meyts P.","year":"2016","unstructured":"De Meyts P.; 2000 The Insulin Receptor and Its Signal Transduction Network. South Dartmouth, MA: Entotext Available from:2016"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1152\/physrev.00062.2017","volume":"99","author":"Dienel G.A.","year":"2019","unstructured":"Dienel G.A.; Brain glucose metabolism: Integration of energetics with function. Physiol. Rev. 2019,99(1),949-1045"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"9075","DOI":"10.1007\/s12035-018-1044-6","volume":"55","author":"Rehni A.K.","year":"2018","unstructured":"Rehni A.K.; Dave K.R.; Impact of hypoglycemia on brain metabolism during diabetes. Mol. Neurobiol. 2018,55(12),9075-9088"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2019.02.027","volume":"209","author":"Pinchefsky E.F.","year":"2019","unstructured":"Pinchefsky E.F.; Hahn C.D.; Kamino D.; Hyperglycemia and glucose variability are associated with worse brain function and seizures in neonatal encephalopathy: A prospective cohort study. J. Pediatr. 2019,209,23-32"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.pan.2017.09.007","volume":"17","author":"Bharmal S.H.","year":"2017","unstructured":"Bharmal S.H.; Pendharkar S.A.; Singh R.G.; Goodarzi M.O.; Pandol S.J.; Petrov M.S.; Relationship between circulating levels of pancreatic proteolytic enzymes and pancreatic hormones. Pancreatology 2017,17(6),876-883"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cbi.2016.08.016","volume":"258","author":"Arafa N.M.S.","year":"2016","unstructured":"Arafa N.M.S.; Marie M-A.S.; AlAzimi S.A.M.; Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model. Chem. Biol. Interact. 2016,258,79-88"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.22038\/IJBMS.2018.29810.7197","volume":"21","author":"Lin L-W.","year":"2018","unstructured":"Lin L-W.; Tsai F.S.; Yang W.T.; Differential change in cortical and hippocampal monoamines, and behavioral patterns in streptozotocin-induced type 1 diabetic rats. Iran. J. Basic Med. Sci. 2018,21(10),1026-1034"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bcp.2018.01.024","volume":"153","author":"Rahman M.H.","year":"2018","unstructured":"Rahman M.H.; Bhusal A.; Lee W-H.; Lee I-K.; Suk K.; Hypothalamic inflammation and malfunctioning glia in the pathophysiology of obesity and diabetes: Translational significance. Biochem. Pharmacol. 2018,153,123-133"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/dia.2017.0009","volume":"19","author":"Rubega M.","year":"2017","unstructured":"Rubega M.; Sparacino G.; Neurological changes in hypoglycemia. Diabetes Technol. Ther. 2017,19(2),73-75"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2337\/dc18-1410","volume":"42","author":"Laclaustra M.","year":"2019","unstructured":"Laclaustra M.; Moreno-Franco B.; Lou-Bonafonte J.M.; Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome. Diabetes Care 2019,42(2),303-310"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2174\/1381612823666170317165350","volume":"24","author":"Rojas-Carranza C.A.","year":"2018","unstructured":"Rojas-Carranza C.A.; Bustos-Cruz R.H.; Pino-Pinzon C.J.; Ariza-Marquez Y.V.; Gomez-Bello R.M.; Canadas-Garre M.; Diabetes-related neurological implications and pharmacogenomics. Curr. Pharm. Des. 2018,24(15),1695-1710"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11892-016-0775-x","volume":"16","author":"Zilliox L.A.","year":"2016","unstructured":"Zilliox L.A.; Chadrasekaran K.; Kwan J.Y.; Russell J.W.; Diabetes and cognitive impairment. Curr. Diab. Rep. 2016,16(9),87"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/pedi.12386","volume":"17","author":"Knip M.","year":"2016","unstructured":"Knip M.; Siljander H.; Ilonen J.; Simell O.; Veijola R.; Role of humoral beta-cell autoimmunity in type 1 diabetes. Pediatr. Diabetes 2016,17(Suppl. 22),17-24"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/0271678X19842680","volume":"40","author":"Nwokolo M.","year":"2020","unstructured":"Nwokolo M.; Amiel S.A.; O\u2019Daly O.; Hypoglycemic thalamic activation in type 1 diabetes is associated with preserved symptoms despite reduced epinephrine. J. Cereb. Blood Flow Metab. 2020,40(4),787-798"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"E522","DOI":"10.1532\/hsf.2008","volume":"21","author":"Phadke D.","year":"2018","unstructured":"Phadke D.; Beller J.P.; Tribble C.; The disparate effects of epinephrine and norepinephrine on hyperglycemia in cardiovascular surgery. Heart Surg. Forum 2018,21(6),E522-E526"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1096\/fj.201601381R","volume":"31","author":"Benrick A.","year":"2017","unstructured":"Benrick A.; Kokosar M.; Hu M.; Autonomic nervous system activation mediates the increase in whole-body glucose uptake in response to electroacupuncture. FASEB J. 2017,31(8),3288-3297"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/cphy.c160015","volume":"7","author":"Tups A.","year":"2017","unstructured":"Tups A.; Benzler J.; Sergi D.; Ladyman S.R.; Williams L.M.; Central regulation of glucose homeostasis. Compr. Physiol. 2017,7(2),741-764"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcmgh.2016.09.010","volume":"3","author":"Gurney M.A.","year":"2017","unstructured":"Gurney M.A.; Laubitz D.; Ghishan F.K.; Kiela P.R.; Pathophysiology of intestinal Na\/H exchange. Cell. Mol. Gastroenterol. Hepatol. 2017,3(1),27-40"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.cmet.2018.11.005","volume":"29","author":"Baeza-Lehnert F.","year":"2019","unstructured":"Baeza-Lehnert F.; Saab A.S.; Guti\u00e9rrez R.; Non-canonical control of neuronal energy status by the Na pump. Cell Metab. 2019,29(3),668-680.e4"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1091\/mbc.E18-12-0792","volume":"30","author":"Pan X.","year":"2019","unstructured":"Pan X.; Meriin A.; Huang G.; Kandror K.V.; Insulin-responsive amino peptidase follows the Glut4 pathway but is dispensable for the formation and translocation of insulin-responsive vesicles. Mol. Biol. Cell 2019,30(12),1536-1543"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainresbull.2016.06.005","volume":"133","author":"Tramutola A.","year":"2017","unstructured":"Tramutola A.; Lanzillotta C.; Perluigi M.; Butterfield D.A.; Oxidative stress, protein modification and Alzheimer disease. Brain Res. Bull. 2017,133,88-96"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"Butterfield D.A.","year":"2019","unstructured":"Butterfield D.A.; Halliwell B.; Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 2019,20(3),148-160"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mad.2016.05.005","volume":"161","author":"Abolhassani N","year":"2017","unstructured":"Abolhassani N; Leon J; Sheng Z; Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer\u2019s disease brain. Mech Ageing Dev 2017,161(Pt A),95-104","journal-title":"Mech Ageing Dev"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.fsi.2018.04.046","volume":"78","author":"Lin S-M.","year":"2018","unstructured":"Lin S-M.; Shi C-M.; Mu M-M.; Chen Y-J.; Luo L.; Effect of high dietary starch levels on growth, hepatic glucose metabolism, oxidative status and immune response of juvenile largemouth bass, Micropterus salmoides. Fish Shellfish Immunol. 2018,78,121-126"},{"key":"ref=60","first-page":"67","volume":"24","author":"Tian Y.","year":"2018","unstructured":"Tian Y.; Yang J.; Zhang K.; Zhao J.; Effects of inflammatory response and oxidative stress on the GLUT-1 signal transduction in the placenta of patients with gestational diabetes mellitus. Hainan Yixueyuan Xuebao 2018,24(2),67-70"},{"key":"ref=61","doi-asserted-by":"publisher","DOI":"10.1515\/jcim-2016-0111","volume":"14","author":"Mudi S.R.","year":"2017","unstructured":"Mudi S.R.; Akhter M.; Biswas S.K.; Effect of aqueous extract of Aegle marmelos fruit and leaf on glycemic, insulinemic and lipidemic status of type 2 diabetic model rats. J. Complement. Integr. Med. 2017,14(2)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/pr.pr_53_19","volume":"12","author":"Birudu R.","year":"2020","unstructured":"Birudu R.; Pamulapati P.; Manoharan S.; Evaluation of biochemical changes in diabetic rats treated with Aegle marmelos (L.) methanolic leaf extract. Pharmacognosy Res. 2020,12(2),127"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.14260\/jemds\/2016\/1650","volume":"5","author":"Borgohain R.","year":"2016","unstructured":"Borgohain R.; Pathak P.; Mohan R.; Anti-diabetic and Reno-protective effect of the ethanolic extract of solanum indicum in alloxan-induced diabetic rats. J. Evol. Med. Dent. Sci. 2016,5(99),7294-7298"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1080\/1061186X.2017.1419478","volume":"26","author":"Thakur P.","year":"2018","unstructured":"Thakur P.; Kumar A.; Kumar A.; Targeting oxidative stress through antioxidants in diabetes mellitus. J. Drug Target. 2018,26(9),766-776"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"5","DOI":"10.12816\/0003082","volume":"12","author":"Matough F.A.","year":"2012","unstructured":"Matough F.A.; Budin S.B.; Hamid Z.A.; Alwahaibi N.; Mohamed J.; The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ. Med. J. 2012,12(1),5-18"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00404-015-3851-6","volume":"293","author":"Aydemir B.","year":"2016","unstructured":"Aydemir B.; Baykara O.; Cinemre F.B.; LOX-1 gene variants and maternal levels of plasma oxidized LDL and malondialdehyde in patients with gestational diabetes mellitus. Arch. Gynecol. Obstet. 2016,293(3),517-527"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.dsx.2017.12.029","volume":"12","author":"Robson R.","year":"2018","unstructured":"Robson R.; Kundur A.R.; Singh I.; Oxidative stress biomarkers in type 2 diabetes mellitus for assessment of cardiovascular disease risk. Diabetes Metab. Syndr. 2018,12(3),455-462"},{"key":"ref=68","first-page":"1006","volume":"1","author":"Jebur A.","year":"2016","unstructured":"Jebur A.; Mokhamer M.; El-Demerdash F.; A review on oxidative stress and role of antioxidants in diabetes mellitus. Austin endocrinol. Diabetes Case Reports 2016,1,1006"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-397153-1.00001-9","author":"Henriksen E.J.","year":"2019","unstructured":"Henriksen E.J.; Role of oxidative stress in the pathogenesis of insulin resistance and type 2 diabetes. In: Bioactive Food as Dietary Interventions for Diabetes. Tucson, AZ, USA: Acedemic Press 2019,3-17"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.jdiacomp.2016.07.011","volume":"30","author":"de Souza Bastos A.","year":"2016","unstructured":"de Souza Bastos A.; Graves D.T.; de Melo Loureiro A.P.; Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients. J. Diabetes Complications 2016,30(8),1593-1599"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13098-018-0318-5","volume":"10","author":"Balbi M.E.","year":"2018","unstructured":"Balbi M.E.; Tonin F.S.; Mendes A.M.; Antioxidant effects of vitamins in type 2 diabetes: A meta-analysis of randomized controlled trials. Diabetol. Metab. Syndr. 2018,10(1),18"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41419-017-0135-z","volume":"9","author":"Volpe C.M.O.","year":"2018","unstructured":"Volpe C.M.O.; Villar-Delfino P.H.; Dos Anjos P.M.F.; Nogueira-Machado J.A.; Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018,9(2),119"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1474-4422(13)70261-8","volume":"13","author":"Hagberg H.","year":"2014","unstructured":"Hagberg H.; Mallard C.; Rousset C.I.; Thornton C.; Mitochondria: Hub of injury responses in the developing brain. Lancet Neurol. 2014,13(2),217-232"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"Brownlee M.","year":"2005","unstructured":"Brownlee M.; The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005,54(6),1615-1625"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-1-4614-0631-0_37","author":"Zhong Y.","year":"2012","unstructured":"Zhong Y.; Wang J.J.; Zhang S.X.; Intermittent but not constant high glucose induces ER stress and inflammation in human retinal pericytes. In: Retinal degenerative disease. Boston, MA: Springer 2012,285-292"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/cbf.3113","volume":"33","author":"Yorulmaz H.","year":"2015","unstructured":"Yorulmaz H.; Kaptan E.; Seker F.B.; Oztas B.; Type 1 diabetes exacerbates blood-brain barrier alterations during experimental epileptic seizures in an animal model. Cell Biochem. Funct. 2015,33(5),285-292"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1292\/jvms.15-0589","volume":"78","author":"Yoo D.Y.","year":"2016","unstructured":"Yoo D.Y.; Yim H.S.; Jung H.Y.; Chronic type 2 diabetes reduces the integrity of the blood-brain barrier by reducing tight junction proteins in the hippocampus. J. Vet. Med. Sci. 2016,78(6),957-962"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.physbeh.2012.05.015","volume":"107","author":"Davidson T.L.","year":"2012","unstructured":"Davidson T.L.; Monnot A.; Neal A.U.; Martin A.A.; Horton J.J.; Zheng W.; The effects of a high-energy diet on hippocampal-dependent discrimination performance and blood-brain barrier integrity differ for diet-induced obese and diet-resistant rats. Physiol. Behav. 2012,107(1),26-33"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.2337\/db10-0365","volume":"59","author":"Chronopoulos A.","year":"2010","unstructured":"Chronopoulos A.; Tang A.; Beglova E.; Trackman P.C.; Roy S.; High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: Mechanism for compromised extracellular matrix barrier function. Diabetes 2010,59(12),3159-3166"},{"key":"ref=80","first-page":"732","volume":"20","author":"Tien T.","year":"2014","unstructured":"Tien T.; Muto T.; Barrette K.; Challyandra L.; Roy S.; Downregulation of Connexin 43 promotes vascular cell loss and excess permeability associated with the development of vascular lesions in the diabetic retina. Mol. Vis. 2014,20,732-741"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00125-006-0485-z","volume":"50","author":"Hawkins B.T.","year":"2007","unstructured":"Hawkins B.T.; Lundeen T.F.; Norwood K.M.; Brooks H.L.; Egleton R.D.; Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: Contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 2007,50(1),202-211"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.neurobiolaging.2013.01.012","volume":"34","author":"Shimizu F.","year":"2013","unstructured":"Shimizu F.; Sano Y.; Tominaga O.; Maeda T.; Abe M.A.; Kanda T.; Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-\u03b2 by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro. Neurobiol. Aging 2013,34(7),1902-1912"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuroscience.2011.11.062","volume":"202","author":"Wang J.","year":"2012","unstructured":"Wang J.; Li G.; Wang Z.; High glucose-induced expression of inflammatory cytokines and reactive oxygen species in cultured astrocytes. Neuroscience 2012,202,58-68"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3892\/mmr.2017.6772","volume":"16","author":"Xie Y.","year":"2017","unstructured":"Xie Y.; Yu N.; Chen Y.; Zhang K.; Ma H.Y.; Di Q.; HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains via the RAGE\/NF-\u03baB signaling pathway. Mol. Med. Rep. 2017,16(2),1691-1700"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1139\/cjpp-2019-0421","volume":"98","author":"Singh H.","year":"2020","unstructured":"Singh H.; Sodhi R.K.; Chahal S.K.; Madan J.; Meclizine ameliorates memory deficits in streptozotocin-induced experimental dementia in mice: role of nuclear pregnane X receptors. Can. J. Physiol. Pharmacol. 2020,98(6),383-390"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11892-014-0573-2","volume":"15","author":"Arboleda-Velasquez J.F.","year":"2015","unstructured":"Arboleda-Velasquez J.F.; Valdez C.N.; Marko C.K.; D\u2019Amore P.A.; From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy. Curr. Diab. Rep. 2015,15(2),573"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15226\/2374-6890\/2\/2\/00123","volume":"2","author":"Patrick P.","year":"2015","unstructured":"Patrick P.; Price T.O.; Diogo A.L.; Sheibani N.; Banks W.A.; Shah G.N.; Topiramate protects pericytes from glucotoxicity: Role for mitochondrial CA VA in cerebromicrovascular disease in diabetes. J. Endocrinol. Diabetes 2015,2(2),1-7"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1177\/0271678X15606149","volume":"36","author":"Persidsky Y.","year":"2016","unstructured":"Persidsky Y.; Hill J.; Zhang M.; Dysfunction of brain pericytes in chronic neuroinflammation. J. Cereb. Blood Flow Metab. 2016,36(4),794-807"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1478-811X-11-38","volume":"11","author":"Xie X.","year":"2013","unstructured":"Xie X.; Lan T.; Chang X.; Connexin43 mediates NF-\u03baB signalling activation induced by high glucose in GMCs: Involvement of c-Src. Cell Commun. Signal. 2013,11(1),38"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/HYPERTENSIONAHA.112.192401","volume":"59","author":"Min L.J.","year":"2012","unstructured":"Min L.J.; Mogi M.; Shudou M.; Peroxisome proliferator-activated receptor-\u03b3 activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice. Hypertension 2012,59(5),1079-1088"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/glia.22575","volume":"61","author":"Alvarez J.I.","year":"2013","unstructured":"Alvarez J.I.; Katayama T.; Prat A.; Glial influence on the blood brain barrier. Glia 2013,61(12),1939-1958"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"e00030","DOI":"10.1042\/AN20090048","volume":"2","author":"Gandhi G.K.","year":"2010","unstructured":"Gandhi G.K.; Ball K.K.; Cruz N.F.; Dienel G.A.; Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro 2010,2(2),e00030"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/B978-0-444-63432-0.00003-7","author":"Obermeier B.","year":"2016","unstructured":"Obermeier B.; Verma A.; Ransohoff R.M.; The blood-brain barrier. 2016,39-59"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/svn-2018-000198","volume":"4","author":"Xu L.","year":"2018","unstructured":"Xu L.; Nirwane A.; Yao Y.; Basement membrane and blood-brain barrier. Stroke Vasc. Neurol. 2018,4(2),78-82"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4172\/2329-6887.1000125","volume":"2","author":"Prasad S.","year":"2014","unstructured":"Prasad S.; Sajja R.K.; Naik P.; Cucullo L.; Diabetes mellitus and blood-brain barrier dysfunction: An overview. J. Pharmacovigil. 2014,2(2),125"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3389\/fnins.2018.01019","volume":"12","author":"Pulgar V.M.","year":"2019","unstructured":"Pulgar V.M.; Transcytosis to cross the blood brain barrier, new advancements and challenges. Front. Neurosci. 2019,12,1019"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.biomaterials.2018.07.014","volume":"180","author":"Campisi M.","year":"2018","unstructured":"Campisi M.; Shin Y.; Osaki T.; Hajal C.; Chiono V.; Kamm R.D.; 3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes. Biomaterials 2018,180,117-129"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"Bell R.D.","year":"2009","unstructured":"Bell R.D.; Zlokovic B.V.; Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol. 2009,118(1),103-113"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"e0150360","DOI":"10.1371\/journal.pone.0150360","volume":"11","author":"Herland A.","year":"2016","unstructured":"Herland A.; van der Meer A.D.; FitzGerald E.A.; Park T.E.; Sleeboom J.J.; Ingber D.E.; Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip. PLoS One 2016,11(3),e0150360"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/JLB.1RU1117-428R","volume":"103","author":"Sonar S.A.","year":"2018","unstructured":"Sonar S.A.; Lal G.; Blood-brain barrier and its function during inflammation and autoimmunity. J. Leukoc. Biol. 2018,103(5),839-853"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1172\/JCI95769","volume":"127","author":"Quintana F.J.","year":"2017","unstructured":"Quintana F.J.; Astrocytes to the rescue! Glia limitans astrocytic endfeet control CNS inflammation. J. Clin. Invest. 2017,127(8),2897-2899"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3892\/etm.2017.4760","volume":"14","author":"Zhang S.","year":"2017","unstructured":"Zhang S.; Wu M.; Peng C.; Zhao G.; Gu R.; GFAP expression in injured astrocytes in rats. Exp. Ther. Med. 2017,14(3),1905-1908"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"107.a","DOI":"10.1007\/s11892-018-1069-2","volume":"18","author":"Carnagarin R","year":"2018","unstructured":"Carnagarin R; Matthews VB; Herat LY; Ho JK; Schlaich MP; Autonomic regulation of glucose homeostasis: A specific role for sympathetic nervous system activation. Curr Diab Rep 2018,18(11),107.a"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.neuroimage.2016.07.017","volume":"158","author":"Xu Z.","year":"2017","unstructured":"Xu Z.; Zeng W.; Sun J.; The quantification of blood-brain barrier disruption using dynamic contrast-enhanced magnetic resonance imaging in aging rhesus monkeys with spontaneous type 2 diabetes mellitus. Neuroimage 2017,158,480-487"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/1479164116683149","volume":"14","author":"Acharya N.K.","year":"2017","unstructured":"Acharya N.K.; Qi X.; Goldwaser E.L.; Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA inhibitor Darapladib. Diab. Vasc. Dis. Res. 2017,14(3),200-213"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"H2660","DOI":"10.1152\/ajpheart.00489.2006","volume":"291","author":"Huber J.D.","year":"2006","unstructured":"Huber J.D.; VanGilder R.L.; Houser K.A.; Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am. J. Physiol. Heart Circ. Physiol. 2006,291(6),H2660-H2668"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/jdi.12545","volume":"8","author":"Umemura T.","year":"2017","unstructured":"Umemura T.; Kawamura T.; Hotta N.; Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities. J. Diabetes Investig. 2017,8(2),134-148"},{"key":"ref=108","first-page":"65","volume":"4","author":"Kanyal N.","year":"2015","unstructured":"Kanyal N.; The science of ischemic stroke: Pathophysiology and pharmacological treatment. Int. J. Pharma Res. Rev. 2015,4,65-84"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers W.J.","year":"2019","unstructured":"Powers W.J.; Rabinstein A.A.; Ackerson T.; Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 2019,50(12),e344-e418"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/1566523220999200726225457","volume":"20","author":"Shah P.","year":"2020","unstructured":"Shah P.; Chavda V.; Patel S.; Bhadada S.; Ashraf G.M.; Promising anti-stroke signature of voglibose: Investigation through in silico molecular docking and virtual screening in in vivo animal studies. Curr. Gene Ther. 2020,20(3),223-235"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/BF00402176","volume":"38","author":"Stegmayr B.","year":"1995","unstructured":"Stegmayr B.; Asplund K.; Diabetes as a risk factor for stroke. A population perspective. Diabetologia 1995,38(9),1061-1068"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"Forbes J.M.","year":"2013","unstructured":"Forbes J.M.; Cooper M.E.; Mechanisms of diabetic complications. Physiol. Rev. 2013,93(1),137-188"},{"key":"ref=113","doi-asserted-by":"publisher","DOI":"10.5772\/53774","author":"Humberto C-M.","year":"2013","unstructured":"Humberto C-M.; Neurodegenerative Diseases. 2013"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12974-016-0774-5","volume":"14","author":"Shukla V.","year":"2017","unstructured":"Shukla V.; Shakya A.K.; Perez-Pinzon M.A.; Dave K.R.; Cerebral ischemic damage in diabetes: An inflammatory perspective. J Neuroinflam 2017,14(1),21"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","volume":"34","author":"Paneni F.","year":"2013","unstructured":"Paneni F.; Beckman J.A.; Creager M.A.; Cosentino F.; Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: part I. Eur. Heart J. 2013,34(31),2436-2443"},{"key":"ref=116","first-page":"326","volume":"53","author":"Zavoreo I.","year":"2014","unstructured":"Zavoreo I.; Mad\u017ear Z.; Demarin V.; Kes V.B.; Vascular cognitive impairment in diabetes mellitus: Are prevention and treatment effective? Acta Clin. Croat. 2014,53(3),326-333"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jgh.14451","volume":"34","author":"Wynne K.","year":"2019","unstructured":"Wynne K.; Devereaux B.; Dornhorst A.; Diabetes of the exocrine pancreas. J. Gastroenterol. Hepatol. 2019,34(2),346-354"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.neubiorev.2013.03.010","volume":"37","author":"Ho N.","year":"2013","unstructured":"Ho N.; Sommers M.S.; Lucki I.; Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression. Neurosci. Biobehav. Rev. 2013,37(8),1346-1362"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2337\/db14-0348","volume":"63","author":"Biessels G.J.","year":"2014","unstructured":"Biessels G.J.; Reijmer Y.D.; Brain changes underlying cognitive dysfunction in diabetes: What can we learn from MRI? Diabetes 2014,63(7),2244-2252"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2337\/dc08-2143","volume":"32","author":"Ruis C.","year":"2009","unstructured":"Ruis C.; Biessels G.J.; Gorter K.J.; van den Donk M.; Kappelle L.J.; Rutten G.E.; Cognition in the early stage of type 2 diabetes. Diabetes Care 2009,32(7),1261-1265"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/1573399811666150515125349","volume":"12","author":"Zanoveli J.M.","year":"2016","unstructured":"Zanoveli J.M.; Morais H.; Dias I.C.; Schreiber A.K.; Souza C.P.; Cunha J.M.; Depression associated with diabetes: From pathophysiology to treatment. Curr. Diabetes Rev. 2016,12(3),165-178"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13195-015-0130-5","volume":"7","author":"Feinkohl I.","year":"2015","unstructured":"Feinkohl I.; Price J.F.; Strachan M.W.J.; Frier B.M.; The impact of diabetes on cognitive decline: Potential vascular, metabolic, and psychosocial risk factors. Alzheimers Res. Ther. 2015,7(1),46"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12975-020-00872-3","volume":"12","author":"Jiang Y.","year":"2021","unstructured":"Jiang Y.; Liu N.; Han J.; Diabetes mellitus\/poststroke hyperglycemia: A detrimental factor for tPA thrombolytic stroke therapy. Transl. Stroke Res. 2021,12(3),416-427"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijdm.2011.01.001","volume":"3","author":"Hazari M.A.H.","year":"2015","unstructured":"Hazari M.A.H.; Ram Reddy B.; Uzma N.; Santhosh Kumar B.; Cognitive impairment in type 2 diabetes mellitus. Int. J. Diabetes Mellit. 2015,3(1),19-24"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/1533317510365343","volume":"25","author":"Mizrahi E.H.","year":"2010","unstructured":"Mizrahi E.H.; Waitzman A.; Blumstein T.; Arad M.; Adunsky A.; Diabetes mellitus predicts cognitive impairment in patients with ischemic stroke. Am. J. Alzheimers Dis. Other Demen. 2010,25(4),362-366"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/nyas.13217","volume":"1391","author":"Joseph J.J.","year":"2017","unstructured":"Joseph J.J.; Golden S.H.; Cortisol dysregulation: The bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann. N. Y. Acad. Sci. 2017,1391(1),20-34"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jdiacomp.2016.09.013","volume":"31","author":"Asuzu C.C.","year":"2017","unstructured":"Asuzu C.C.; Walker R.J.; Williams J.S.; Egede L.E.; Pathways for the relationship between diabetes distress, depression, fatalism and glycemic control in adults with type 2 diabetes. J. Diabetes Complications 2017,31(1),169-174"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S2213-8587(15)00134-5","volume":"3","author":"Moulton C.D.","year":"2015","unstructured":"Moulton C.D.; Pickup J.C.; Ismail K.; The link between depression and diabetes: The search for shared mechanisms. Lancet Diabetes Endocrinol. 2015,3(6),461-471"},{"key":"ref=129","first-page":"1","author":"Teasell R.","year":"2018","unstructured":"Teasell R.; Salter K.; Faltynek P.; Cotoi A.; Eskes G.; Post-stroke cognitive disorders. In: Evidence-Based Rev 2018,1-86","journal-title":"In: Evidence-Based Rev"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"828435","DOI":"10.1155\/2014\/828435","volume":"2014","author":"Ovbiagele B.","year":"2014","unstructured":"Ovbiagele B.; Kautz S.; Feng W.; Adkins D.L.; Poststroke outcomes. Stroke Res. Treat. 2014,2014,828435"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/jnnp-2016-313361","volume":"87","author":"Crichton S.L.","year":"2016","unstructured":"Crichton S.L.; Bray B.D.; McKevitt C.; Rudd A.G.; Wolfe C.D.; Patient outcomes up to 15 years after stroke: Survival, disability, quality of life, cognition and mental health. J. Neurol. Neurosurg. Psychiatry 2016,87(10),1091-1098"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3389\/fncel.2014.00319","volume":"8","author":"Shichita T.","year":"2014","unstructured":"Shichita T.; Ito M.; Yoshimura A.; Post-ischemic inflammation regulates neural damage and protection. Front. Cell. Neurosci. 2014,8,319"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12902-019-0371-6","volume":"19","author":"Sheikhbahaei S.","year":"2019","unstructured":"Sheikhbahaei S.; Manizheh D.; Mohammad S.; Can MiR-503 be used as a marker in diabetic patients with ischemic stroke? BMC Endocr. Disord. 2019,19(1),42"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1161\/STROKEAHA.119.025699","volume":"50","author":"Lyden P.D.","year":"2019","unstructured":"Lyden P.D.; Thrombolytic therapy for acute ischemic stroke. Stroke 2019,50(9),2597-2603"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/2040622310394032","volume":"2","author":"Robinson T.","year":"2011","unstructured":"Robinson T.; Zaheer Z.; Mistri A.K.; Thrombolysis in acute ischaemic stroke: An update. Ther. Adv. Chronic Dis. 2011,2(2),119-131"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1161\/01.CIR.94.5.1167","volume":"94","author":"Adams H.P.","year":"1996","unstructured":"Adams H.P.; Brott T.G.; Furlan A.J.; Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1996,94(5),1167-1174"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40256-013-0007-6","volume":"13","author":"Bansal S.","year":"2013","unstructured":"Bansal S.; Sangha K.S.; Khatri P.; Drug treatment of acute ischemic stroke. Am. J. Cardiovasc. Drugs 2013,13(1),57-69"},{"key":"ref=138","first-page":"396","volume":"17","author":"Shahpouri M.M.","year":"2012","unstructured":"Shahpouri M.M.; Mousavi S.; Khorvash F.; Mousavi S.M.; Hoseini T.; Anticoagulant therapy for ischemic stroke: A review of literature. J. Res. Med. Sci. 2012,17(4),396-401"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1161\/01.STR.0000028456.18614.93","volume":"33","author":"Coull B.M.","year":"2002","unstructured":"Coull B.M.; Williams L.S.; Goldstein L.B.; Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke 2002,33(7),1934-1942"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(13)70255-2","volume":"13","author":"Hankey G.J.","year":"2014","unstructured":"Hankey G.J.; Secondary stroke prevention. Lancet Neurol. 2014,13(2),178-194"},{"key":"ref=141","first-page":"303","volume":"116","author":"Stringberg A.","year":"2019","unstructured":"Stringberg A.; Camden R.; Qualls K.; Naqvi S.H.; Update on dual antiplatelet therapy for secondary stroke prevention. Mo. Med. 2019,116(4),303-307"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"l2211","DOI":"10.1136\/bmj.l2211","volume":"365","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Chen W.; Lin Y.; Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: Open label, blinded endpoint, randomised controlled phase II trial. BMJ 2019,365,l2211"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12883-020-01808-y","volume":"20","author":"Albay C.E.Q.","year":"2020","unstructured":"Albay C.E.Q.; Leyson F.G.D.; Cheng F.C.; Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis. BMC Neurol. 2020,20(1),224"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13311-011-0060-2","volume":"8","author":"Yip S.","year":"2011","unstructured":"Yip S.; Benavente O.; Antiplatelet agents for stroke prevention. Neurotherapeutics 2011,8(3),475-487"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/jamaneurol.2019.0079","volume":"76","author":"Spence J.D.","year":"2019","unstructured":"Spence J.D.; Viscoli C.M.; Inzucchi S.E.; Pioglitazone therapy in patients with stroke and prediabetes: A post hoc analysis of the IRIS randomized clinical trial. JAMA Neurol. 2019,76(5),526-535"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.mcna.2018.10.001","volume":"103","author":"Caprio F.Z.","year":"2019","unstructured":"Caprio F.Z.; Sorond F.A.; Cerebrovascular disease: Primary and secondary stroke prevention. Med. Clin. North Am. 2019,103(2),295-308"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/B978-0-444-63600-3.00010-6","author":"McDermott M.","year":"2017","unstructured":"McDermott M.; Jacobs T.; Morgenstern L.; Critical care in acute ischemic stroke. In: Handbook of Clinical Neurology. MI, USA: Elsevier 2017,153-176"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3174\/ajnr.A2169","volume":"31","author":"Jahan R.","year":"2010","unstructured":"Jahan R.; Solitaire flow-restoration device for treatment of acute ischemic stroke: Safety and recanalization efficacy study in a swine vessel occlusion model. AJNR Am. J. Neuroradiol. 2010,31(10),1938-1943"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fneur.2018.00034","volume":"9","author":"Marei H.E.","year":"2018","unstructured":"Marei H.E.; Hasan A.; Rizzi R.; Potential of stem cell-based therapy for ischemic stroke. Front. Neurol. 2018,9,34"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuron.2015.05.041","volume":"87","author":"George P.M.","year":"2015","unstructured":"George P.M.; Steinberg G.K.; Novel stroke therapeutics: Unraveling stroke pathophysiology and its impact on clinical treatments. Neuron 2015,87(2),297-309"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbr.2016.08.029","volume":"340","author":"Alawieh A.","year":"2018","unstructured":"Alawieh A.; Zhao J.; Feng W.; Factors affecting post-stroke motor recovery: Implications on neurotherapy after brain injury. Behav. Brain Res. 2018,340,94-101"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/sctm.18-0014","volume":"7","author":"Venkat P.","year":"2018","unstructured":"Venkat P.; Chopp M.; Chen J.; Cell-based and exosome therapy in diabetic stroke. Stem Cells Transl. Med. 2018,7(6),451-455"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1161\/STROKEAHA.119.025371","volume":"50","author":"Venkat P.","year":"2019","unstructured":"Venkat P.; Cui C.; Chopp M.; MiR-126 mediates brain endothelial cell exosome treatment\u2013induced neurorestorative effects after stroke in type 2 diabetes mellitus mice. Stroke 2019,50(10),2865-2874"},{"key":"ref=154","author":"Collins L.","year":"2020","unstructured":"Collins L.; Costello R.A.; Glucagon-like peptide-1 receptor agonists, statpearls. 2020"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s13300-019-0580-z","volume":"10","author":"Milonas D.","year":"2019","unstructured":"Milonas D.; Didangelos T.; Hatzitolios A.I.; Tziomalos K.; Incretin-based antihyperglycemic agents for the management of acute ischemic stroke in patients with diabetes mellitus: A review. Diabetes Ther. 2019,10(2),429-435"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2017.09.019","volume":"48","author":"Castilla-Guerra L.","year":"2018","unstructured":"Castilla-Guerra L.; Fernandez-Moreno M.D.C.; Leon-Jimenez D.; Carmona-Nimo E.; Antidiabetic drugs and stroke risk. Current evidence. Eur. J. Intern. Med. 2018,48,1-5"},{"key":"ref=157","first-page":"509","volume":"35","author":"Pathak R.","year":"2010","unstructured":"Pathak R.; Bridgeman M.B.; Dipeptidyl peptidase-4 (DPP-4) inhibitors in the management of diabetes. PandT 2010,35(9),509-513"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1161\/STROKEAHA.118.023009","volume":"50","author":"Zhou Z.","year":"2019","unstructured":"Zhou Z.; Lindley R.I.; R\u00e5dholm K.; Canagliflozin and stroke in type 2 diabetes mellitus. Stroke 2019,50(2),396-404"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/dom.13295","volume":"20","author":"Guo M.","year":"2018","unstructured":"Guo M.; Ding J.; Li J.; SGLT2 inhibitors and risk of stroke in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes. Metab. 2018,20(8),1977-1982"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"e014908","DOI":"10.1161\/JAHA.119.014908","volume":"9","author":"Arnott C.","year":"2020","unstructured":"Arnott C.; Li Q.; Kang A.; Sodium-glucose cotransporter 2 inhibition for the prevention of cardiovascular events in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. J. Am. Heart Assoc. 2020,9(3),e014908"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"l4772","DOI":"10.1136\/bmj.l4772","volume":"366","author":"Pasternak B.","year":"2019","unstructured":"Pasternak B.; Ueda P.; Eliasson B.; Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study. BMJ 2019,366,l4772"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/molecules21091136","volume":"21","author":"Choi C.I.","year":"2016","unstructured":"Choi C.I.; Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors from natural products: Discovery of next-generation antihyperglycemic agents. Molecules 2016,21(9),1136"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S1474-4422(09)70051-1","volume":"8","author":"den Hertog H.M.","year":"2009","unstructured":"den Hertog H.M.; van der Worp H.B.; van Gemert H.M.; The paracetamol (Acetaminophen) in stroke (PAIS) trial: A multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol. 2009,8(5),434-440"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/j.apmr.2005.07.306","volume":"86","author":"Golden S.H.","year":"2005","unstructured":"Golden S.H.; Hill-Briggs F.; Williams K.; Stolka K.; Mayer R.S.; Management of diabetes during acute stroke and inpatient stroke rehabilitation. Arch. Phys. Med. Rehabil. 2005,86(12),2377-2384"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4239\/wjd.v5.i2.84","volume":"5","author":"Magkou D.","year":"2014","unstructured":"Magkou D.; Tziomalos K.; Antidiabetic treatment, stroke severity and outcome. World J. Diabetes 2014,5(2),84-88"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.medcle.2018.01.017","volume":"150","author":"Fuentes B.","year":"2018","unstructured":"Fuentes B.; Antidiabetic drugs for stroke prevention in patients with type-2 diabetes. The neurologist\u2019s point of view. In: Med Cl\u00ednica (English Ed) 2018,150,275-281","journal-title":"In: Med Cl\u00ednica (English Ed)"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5853\/jos.2019.00038","volume":"21","author":"Ahn C.H.","year":"2019","unstructured":"Ahn C.H.; Lim S.; Effects of thiazolidinedione and new antidiabetic agents on stroke. J. Stroke 2019,21(2),139-150"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"9756429","DOI":"10.1155\/2017\/9756429","volume":"2017","author":"Arbel\u00e1ez-Quintero I.","year":"2017","unstructured":"Arbel\u00e1ez-Quintero I.; Palacios M.; To use or not to use metformin in cerebral ischemia: A review of the application of metformin in stroke rodents. Stroke Res. Treat. 2017,2017,9756429"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/dom.13850","volume":"22","author":"Lim S.","year":"2020","unstructured":"Lim S.; Oh T.J.; Dawson J.; Sattar N.; Diabetes drugs and stroke risk: Intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials. Diabetes Obes. Metab. 2020,22(1),6-15"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1503\/cmaj.1041393","volume":"172","author":"Semplicini A.","year":"2005","unstructured":"Semplicini A.; Cal\u00f2 L.; Administering antihypertensive drugs after acute ischemic stroke: Timing is everything. CMAJ 2005,172(5),625-626"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/CPJ.0000000000000085","volume":"4","author":"Bowry R.","year":"2014","unstructured":"Bowry R.; Navalkele D.D.; Gonzales N.R.; Blood pressure management in stroke: Five new things. Neurol. Clin. Pract. 2014,4(5),419-426"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1161\/01.STR.28.12.2557","volume":"28","author":"Gueyffier F.","year":"1997","unstructured":"Gueyffier F.; Boissel J.P.; Boutitie F.; Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke 1997,28(12),2557-2562"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/STROKEAHA.110.579375","volume":"41","author":"Khan N.A.","year":"2010","unstructured":"Khan N.A.; Yun L.; Humphries K.; Kapral M.; Antihypertensive drug use and adherence after stroke: Are there sex differences? Stroke 2010,41(7),1445-1449"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13041-018-0357-8","volume":"11","author":"Wu Q.J.","year":"2018","unstructured":"Wu Q.J.; Tymianski M.; Targeting NMDA receptors in stroke: New hope in neuroprotection. Mol. Brain 2018,11(1),15"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(02)00164-3","volume":"1","author":"Ikonomidou C.","year":"2002","unstructured":"Ikonomidou C.; Turski L.; Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002,1(6),383-386"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/1073858412447875","volume":"19","author":"Akpan N.","year":"2013","unstructured":"Akpan N.; Troy C.M.; Caspase inhibitors: Prospective therapies for stroke. Neuroscientist 2013,19(2),129-136"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/978-3-319-95948-1_17","author":"Awosika O.O.","year":"2019","unstructured":"Awosika O.O.; Cohen L.G.;  In: Practical Guide to Transcranial Direct Current Stimulation 2019,509-539","journal-title":"In: Practical Guide to Transcranial Direct Current Stimulation"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/archneur.65.12.1571","volume":"65","author":"Schlaug G.","year":"2008","unstructured":"Schlaug G.; Renga V.; Nair D.; Transcranial direct current stimulation in stroke recovery. Arch. Neurol. 2008,65(12),1571-1576"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"101620","DOI":"10.1016\/j.nicl.2018.101620","volume":"21","author":"Du J.","year":"2019","unstructured":"Du J.; Yang F.; Hu J.; Effects of high- and low-frequency repetitive transcranial magnetic stimulation on motor recovery in early stroke patients: Evidence from a randomized controlled trial with clinical, neurophysiological and functional imaging assessments. Neuroimage Clin. 2019,21,101620"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/RNN-2011-0611","volume":"29","author":"Hoyer E.H.","year":"2011","unstructured":"Hoyer E.H.; Celnik P.A.; Understanding and enhancing motor recovery after stroke using transcranial magnetic stimulation. Restor. Neurol. Neurosci. 2011,29(6),395-409"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2016.0276","volume":"315","author":"Winstein C.J.","year":"2016","unstructured":"Winstein C.J.; Wolf S.L.; Dromerick A.W.; Effect of a task-oriented rehabilitation program on upper extremity recovery following motor stroke the ICARE randomized clinical trial. JAMA 2016,315(6),571-581"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1310\/tsr1406-22","volume":"14","author":"Brewer B.R.","year":"2007","unstructured":"Brewer B.R.; McDowell S.K.; Worthen-Chaudhari L.C.; Poststroke upper extremity rehabilitation: A review of robotic systems and clinical results. Top. Stroke Rehabil. 2007,14(6),22-44"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/STROKEAHA.111.000342","volume":"44","author":"Brainin M.","year":"2013","unstructured":"Brainin M.; Zorowitz R.D.; Advances in stroke: Recovery and rehabilitation. Stroke 2013,44(2),311-313"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5853\/jos.2013.15.3.174","volume":"15","author":"Chang W.H.","year":"2013","unstructured":"Chang W.H.; Kim Y-H.; Robot-assisted therapy in stroke rehabilitation. J. Stroke 2013,15(3),174-181"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1097\/PHM.0b013e31826bcd80","volume":"91","author":"Krebs H.I.","year":"2012","unstructured":"Krebs H.I.; Hogan N.; Robotic therapy: The tipping point. Am. J. Phys. Med. Rehabil. 2012,91(11)(Suppl. 3),S290-S297"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"CD006876","DOI":"10.1002\/14651858.CD006876.pub5","volume":"9","author":"Mehrholz J.","year":"2018","unstructured":"Mehrholz J.; Pohl M.; Platz T.; Kugler J.; Elsner B.; Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst. Rev. 2018,9(9),CD006876"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"S270","DOI":"10.1097\/PHM.0b013e31826bcd42","volume":"91","author":"Schweighofer N.","year":"2012","unstructured":"Schweighofer N.; Choi Y.; Winstein C.; Gordon J.; Task-oriented rehabilitation robotics. Am. J. Phys. Med. Rehabil. 2012,91(11)(Suppl. 3),S270-S279"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3233\/NRE-172408","volume":"43","author":"Weber L.M.","year":"2018","unstructured":"Weber L.M.; Stein J.; The use of robots in stroke rehabilitation: A narrative review. NeuroRehabilitation 2018,43(1),99-110"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1682\/JRRD.2010.10.0210","volume":"49","author":"Norouzi-Gheidari N.","year":"2012","unstructured":"Norouzi-Gheidari N.; Archambault P.S.; Fung J.; Effects of robot-assisted therapy on stroke rehabilitation in upper limbs: Systematic review and meta-analysis of the literature. J. Rehabil. Res. Dev. 2012,49(4),479-496"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/WCO.0b013e32833e99a4","volume":"23","author":"Balasubramanian S.","year":"2010","unstructured":"Balasubramanian S.; Klein J.; Burdet E.; Robot-assisted rehabilitation of hand function. Curr. Opin. Neurol. 2010,23(6),661-670"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2016.2.FOCUS15637","volume":"40","author":"Azad T.D.","year":"2016","unstructured":"Azad T.D.; Veeravagu A.; Steinberg G.K.; Neurorestoration after stroke. Neurosurg. Focus 2016,40(5),E2"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/acn3.544","volume":"5","author":"Cervera M.A.","year":"2018","unstructured":"Cervera M.A.; Soekadar S.R.; Ushiba J.; Brain-computer interfaces for post-stroke motor rehabilitation: A meta-analysis. Ann. Clin. Transl. Neurol. 2018,5(5),651-663"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/155005941104200410","volume":"42","author":"Silvoni S.","year":"2011","unstructured":"Silvoni S.; Ramos-Murguialday A.; Cavinato M.; Brain-computer interface in stroke: A review of progress. Clin. EEG Neurosci. 2011,42(4),245-252"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.expneurol.2017.03.004","volume":"292","author":"Rehni A.K.","year":"2017","unstructured":"Rehni A.K.; Liu A.; Perez-Pinzon M.A.; Dave K.R.; Diabetic aggravation of stroke and animal models. Exp. Neurol. 2017,292,63-79"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/sj.jcbfm.9600355","volume":"27","author":"Martini S.R.","year":"2007","unstructured":"Martini S.R.; Kent T.A.; Hyperglycemia in acute ischemic stroke: A vascular perspective. J. Cereb. Blood Flow Metab. 2007,27(3),435-451"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.vph.2009.02.004","volume":"51","author":"Ergul A.","year":"2009","unstructured":"Ergul A.; Li W.; Elgebaly M.M.; Bruno A.; Fagan S.C.; Hyperglycemia, diabetes and stroke: Focus on the cerebrovasculature. Vascul. Pharmacol. 2009,51(1),44-49"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/00004647-200101000-00007","volume":"21","author":"Vannucci S.J.","year":"2001","unstructured":"Vannucci S.J.; Willing L.B.; Goto S.; Experimental stroke in the female diabetic, db\/db, mouse. J. Cereb. Blood Flow Metab. 2001,21(1),52-60"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1471-4159.2006.04376.x","volume":"101","author":"Tureyen K.","year":"2007","unstructured":"Tureyen K.; Kapadia R.; Bowen K.K.; Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J. Neurochem. 2007,101(1),41-56"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/jcbfm.2009.221","volume":"30","author":"Kumari R.","year":"2010","unstructured":"Kumari R.; Willing L.B.; Patel S.D.; The PPAR-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob\/ob mouse. J. Cereb. Blood Flow Metab. 2010,30(2),352-360"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/HJH.0b013e32833a551a","volume":"28","author":"Iwanami J.","year":"2010","unstructured":"Iwanami J.; Mogi M.; Tsukuda K.; Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice. J. Hypertens. 2010,28(8),1730-1737"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2377-7-33","volume":"7","author":"Ergul A.","year":"2007","unstructured":"Ergul A.; Elgebaly M.M.; Middlemore M.L.; Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurol. 2007,7(1),33"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.brainres.2013.10.021","volume":"1541","author":"Li W.","year":"2013","unstructured":"Li W.; Qu Z.; Prakash R.; Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats. Brain Res. 2013,1541,106-114"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/jcbfm.2010.120","volume":"30","author":"Elgebaly M.M.","year":"2010","unstructured":"Elgebaly M.M.; Prakash R.; Li W.; Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling. J. Cereb. Blood Flow Metab. 2010,30(12),1928-1938"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1124\/jpet.108.146951","volume":"330","author":"Elewa H.F.","year":"2009","unstructured":"Elewa H.F.; Kozak A.; El-Remessy A.B.; Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats. J. Pharmacol. Exp. Ther. 2009,330(2),532-540"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/HYPERTENSIONAHA.108.124149","volume":"53","author":"Osmond J.M.","year":"2009","unstructured":"Osmond J.M.; Mintz J.D.; Dalton B.; Stepp D.W.; Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat. Hypertension 2009,53(2),381-386"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fnins.2020.00229","volume":"14","author":"Garcia-Serrano A.M.","year":"2020","unstructured":"Garcia-Serrano A.M.; Duarte J.M.N.; Brain metabolism alterations in type 2 diabetes: What did we learn from diet-induced diabetes models? Front. Neurosci. 2020,14,229"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"Hacke W.","year":"2008","unstructured":"Hacke W.; Kaste M.; Bluhmki E.; Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 2008,359(13),1317-1329"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(08)61339-2","volume":"372","author":"Wahlgren N.","year":"2008","unstructured":"Wahlgren N.; Ahmed N.; D\u00e1valos A.; Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): An observational study. Lancet 2008,372(9646),1303-1309"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12933-019-0874-5","volume":"18","author":"Woo M.H.","year":"2019","unstructured":"Woo M.H.; Lee H.S.; Kim J.; Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: A nested case-control study. Cardiovasc. Diabetol. 2019,18(1),67"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5853\/jos.2017.02054","volume":"19","author":"Lee E.J.","year":"2017","unstructured":"Lee E.J.; Kim Y.H.; Kim N.; Kang D.W.; Deep into the brain: Artificial intelligence in stroke imaging. J. Stroke 2017,19(3),277-285"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1743-0003-8-42","volume":"8","author":"Choi Y.","year":"2011","unstructured":"Choi Y.; Gordon J.; Park H.; Schweighofer N.; Feasibility of the adaptive and automatic presentation of tasks (ADAPT) system for rehabilitation of upper extremity function post-stroke. J. Neuroeng. Rehabil. 2011,8(1),42"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1161\/STROKEAHA.110.594937","volume":"42","author":"Dave K.R.","year":"2011","unstructured":"Dave K.R.; Tamariz J.; Desai K.M.; Recurrent hypoglycemia exacerbates cerebral ischemic damage in streptozotocin-induced diabetic rats. Stroke 2011,42(5),1404-1411"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/jama.2015.7149","volume":"314","author":"Gorelick P.B.","year":"2015","unstructured":"Gorelick P.B.; Nyenhuis D.; Stroke and cognitive decline. JAMA 2015,314(1),29-30"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2337\/db09-0902","volume":"59","author":"Li W.","year":"2010","unstructured":"Li W.; Prakash R.; Kelly-Cobbs A.I.; Adaptive cerebral neovascularization in a model of type 2 diabetes: Relevance to focal cerebral ischemia. Diabetes 2010,59(1),228-235"},{"key":"ref=215","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-45514-3","author":"Makrides V.","year":"2017","unstructured":"Makrides V.; Dolgodilina E.; Virgintino D.; Lyck R.; Enzmann G.; The Blood Brain Barrier and Inflammation. 2017"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/BF00404803","volume":"33","author":"Olsson T.","year":"1990","unstructured":"Olsson T.; Viitanen M.; Asplund K.; Eriksson S.; H\u00e4gg E.; Prognosis after stroke in diabetic patients. A controlled prospective study. Diabetologia 1990,33(4),244-249"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s00018-017-2510-4","volume":"74","author":"Orriols M.","year":"2017","unstructured":"Orriols M.; Gomez-Puerto M.C.; Ten Dijke P.; BMP type II receptor as a therapeutic target in pulmonary arterial hypertension. Cell. Mol. Life Sci. 2017,74(16),2979-2995"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"113382","DOI":"10.1016\/j.expneurol.2020.113382","volume":"331","author":"Qian Y.","year":"2020","unstructured":"Qian Y.; Chopp M.; Chen J.; Emerging role of microRNAs in ischemic stroke with comorbidities. Exp. Neurol. 2020,331,113382"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527321666220609200852","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/205810\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527321666220609200852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:44:08Z","timestamp":1698659048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/205810\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":218,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527321666220609200852","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}